checkAd
    BBS-Bioactive Bone Substitutes Aktie
    0,4655
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 28.04.24 Lang & Schwarz
    0,4510
     
    EUR
    21.113 STK
    Geldkurs 28.04.24
    0,4800
     
    EUR
    21.113 STK
    Briefkurs 28.04.24
    ISIN: FI4000260583 · WKN: A2JFPK · Finnland

    Neueste Nachrichten

    Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team
    06.03.24 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)
    26.02.24 · globenewswire · BBS-Bioactive Bone Substitutes
    Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position
    21.02.24 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
    31.01.24 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc: Kimmo Tyni appointed as Product Director of BBS-Bioactive Bone Substitutes Plc
    02.01.24 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc: Merja Haikola appointed as Accountable Director (QP) of BBS-Bioactive Bone Substitutes Plc
    27.12.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2024
    27.12.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Jarmo Halonen
    19.12.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Juliusz Rakowski
    19.12.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc’s rights issue raised gross proceeds of EUR 1.87 million
    18.12.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc: Managers' Transactions – Pekka Jalovaara
    30.11.23 · globenewswire · BBS-Bioactive Bone Substitutes
    BBS-Bioactive Bone Substitutes Plc has received new subscription undertakings and supplements the Investor Memorandum dated 24th of November 2023 relating to the rights offering and publishes updated Basic Information Document
    26.11.23 · globenewswire · BBS-Bioactive Bone Substitutes